Pressure Ulcers During The Covid-19 Pandemic In Intensive Care:A Multicenter Cohort Study
Paulo Alves,Carina Bååth,Tânia Manuel,Sofia Almeida,Ulrika Källman
DOI: https://doi.org/10.1016/j.jtv.2024.06.007
IF: 3.374
2024-06-25
Journal of Tissue Viability
Abstract:Highlights • The overall prevalence of pressure ulcers (PUs) was 15.3% in the study population, with ICU-acquired PUs occurring at an incidence of 14.1%. • A majority of the pressure ulcers documented were located at the anterior part of the body (45.35%), and Category 2 ulcers accounted for 38.40% of cases, followed by Category 3 ulcers at 22.71%. • The presence of COVID-19 significantly increased the risk of developing a pressure ulcer, nearly doubling the risk compared to patients without COVID-19. • Age, COVID-19 infection, use of mechanical ventilation, use of vasopressors, having a Braden risk score ≤ 16 at admission, and length of stay were identified as factors associated with the likelihood of developing an ICU-acquired PUs. Aim The objective of the present study is twofold: to describe the prevalence and incidence of pressure ulcers (PUs) among ICU patients during the COVID-19 pandemic, and to identify the risk factors associated with the development of PUs in this cohort of ICU patients. Materials and Methods Retrospective cohort study of adult critical care patients admitted in two general ICUs of two different countries (Sweden and Portugal) between March 1st, 2020, and April 30th, 2021, through the analysis of the electronic health record database. The prevalence and incidence were calculated, and a multivariate logistic-regression model was used to calculate odds ratios (ORs), of possible risk factors of PU development. Results The sample consisted of 1717 patients. The overall prevalence of PU was 15.3%, and the incidence of ICU-acquired PUs was 14.1%. Most of the pressure ulcers documented in this study were at the anterior part of the body (45.35%) and regarding classification, Category 2 (38.40%) and Category 3 (22.71%) pressure ulcers together accounted for over fifty percent of the cases recorded. In the multivariate logistic regression model for PU, age, having COVID-19 (OR= 1.58, 95% CI: 1.20 – 2.09), use of mechanical ventilation (OR= 1.49, 95% CI: 1.13 = 1.97), use of vasopressors (OR= 1.31, 95% CI: 1.00 – 1.70), having a Braden risk score ≤ 16 at admission (OR= 1.63; 95% CI: 1.04 – 2.56), and length of stay (LOS) (OR = 1.43, 95% CI 1.03 – 2.00 if LOS 90 – 260 hours, OR = 2.34, 95% CI: 1.63 – 3.35 if LOS > 260 hours) were associated with the likelihood of developing an ICU-acquired PUs. Conclusion When adjusted for covariates patients with COVID-19 had a higher risk for PU development during the ICU stay compared to patients without COVID-19. Health care personnel in ICU may consider incorporating COVID-19, age, use of mechanical ventilation, vasopressors and estimated LOS in addition to a comprehensive risk assessment including both a risk score and clinical assessment.
dermatology,nursing